wnwbanner.jpg (27305 bytes)


What's New

About Wing-N-Wave

Purchasing a Labrador

Canine Health & Genetics

Just for Fun!

Canine Legislature

Pamela A. Davol, 76 Mildred Avenue, Swansea, MA  02777-1620.

Cancer In The Canine


Part 1, Part 2, and Part 3.


In Cancer: Principles and Practice of Oncology, 5th edition, V.T. DeVita, Jr., S. Hellman, S.A. Rosenberg (eds.) Lippincott-Raven Publishers, Philadelphia, 1997:


In Cancer Medicine, 4th Edition, Holland, J.F. et al. (eds.), Williams and Wilkins, Baltimore, 1997:


In Kirk's Current Veterinary Therapy XII, Bonagura, J.D. (ed.), W.B. Saunders Co., Philadelphia, 1995:

In Kirk's Current Veterinary Therapy XIII, Bonagura, J.D. (ed.), W.B. Saunders Co., Philadelphia, 1999:


Ma, Y. et al. Clustering of activating mutations in cKIT's juxtamembrane coding region in canine mast cell neoplasms. J. Invest. Dermatol., 112:165-70, 1999.

London, C.A. et al. Spontaneous canine mast cell tumors express tandem duplications in the proto-oncogene c-kit. Exp. Hematol., 27:689-97, 1999.

Rungsipipat, A. et al. Amplification of the c-yes oncogene in canine mammary tumors. J. Vet. Med. Sci., 61:185-9, 1999.

Kaneene, JB and Miller, R. Re-analysis of 2,4-D use and the occurrence of malignant lymphoma. Vet. Hum. Toxicol., 41:164-70, 1999.

Veldhoen, N. et al. Mutations of the p53 gene in canine lymphoma and evidence for germ line p53 mutations in the dog. Oncogene, 16:249-55, 1998.

Kiupel, M. et al. Prognostic factors for treated canine malignant lymphoma. Vet Pathol., 36:292-300, 1999.

Hahn, K.A. et al. Detection and clinical significance of plasma glutathione-s-transferases in dogs with lymphoma. In Vivo, 13:173-5, 1999.

Kiupel, M. et al. The prognostic significance of AgNOR counts and PCNA-positive cell counts in canine malignant lymphoma. J. Comp. Pathol., 119:407-18, 1998.

Bukowski, J.A. et al. Environmental causes for sinonasal cancers in pet dogs, and their usefulness as sentinels of indoor cancer risk. J. Toxicol. Environ. Health, 54:579-91, 1998.

Suzich, J.A. et al. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc. Natl. Acad. Sci. USA, 92:11553-7, 1995.

Coomber, B.L. et al. Blood vessel density in canine osteosarcoma. Can. J. Vet. Res., 62:199-204, 1998.

Marcellin-Little, D.J. et al. Osteosarcoma at the site of bone infarction associated with total hip arthroplasty in a dog. Vet. Surg., 28:54-60, 1999.

Ru, G. et al. Host related risk factors for canine osteosarcoma. Vet. J., 156:31-9, 1998.

Johnson, A.S. et al. Mutation of the p53 tumor suppressor gene in spontaneously occurring osteosarcomas of the dog. Carcinogenesis, 19:213-7, 1998.

Davol PA, Frackelton AR Jr, Calabresi P. Growth-factor toxin chimeras and their applications. In: Growth Factors and Receptors: A Practical Approach. McKay IA, Brown KD (eds), Oxford University Press, Oxford, 1998. pp.199-225.

Copyright 1999, 2000. Pamela A. Davol. All rights reserved. Copyright & disclaimer.

Back To Cancer In The Canine--Table of Contents
Back To Main Menu